Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Neocate LCP powder
0913107A0BDAAAB
|
Neocate powder amino acid formula (0913107) | Powder amino acid formula (0913107) | Nutrition and Blood | 17,149 |
|
SMA Alfamino powder
0913107A0BBAAAA
|
SMA powder amino acid formula | Powder amino acid formula (0913107) | Nutrition and Blood | 10,558 |
|
Nutramigen PurAmino powder
0913107A0BEAAAD
|
Nutramigen powder amino acid formula | Powder amino acid formula (0913107) | Nutrition and Blood | 2,496 |
|
Neocate Syneo powder
0913107A0BDABAC
|
Neocate powder amino acid formula (0913107) | Powder amino acid formula (0913107) | Nutrition and Blood | 1,699 |
|
EleCare powder
0913107A0BCAAAE
|
EleCare powder amino acid formula | Powder amino acid formula (0913107) | Nutrition and Blood | 4 |
|
Generic Neocate LCP powder
0913107A0AAABAB
|
Powder amino acid formula (0913107) | Powder amino acid formula (0913107) | Nutrition and Blood | 1 |
|
Generic EleCare powder gluten free
0913107A0AAAEAE
|
Powder amino acid formula (0913107) | Powder amino acid formula (0913107) | Nutrition and Blood | No data available |
|
Generic Neocate Syneo powder
0913107A0AAACAC
|
Powder amino acid formula (0913107) | Powder amino acid formula (0913107) | Nutrition and Blood | No data available |
|
Generic Nutramigen PurAmino powder
0913107A0AAADAD
|
Powder amino acid formula (0913107) | Powder amino acid formula (0913107) | Nutrition and Blood | No data available |
|
Generic SMA Alfamino powder
0913107A0AAAAAA
|
Powder amino acid formula (0913107) | Powder amino acid formula (0913107) | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.